Table 2 Thromboembolic and bleeding events documented during the follow-up period
From: Optimal INR level for warfarin therapy after mechanical mitral valve replacement
Events | Total (N = 200) | Per 100 person-years |
|---|---|---|
Thromboembolic events, n (%) | 13 (6.5%) | 3.42 |
-Stroke | 9 (4.5%) | |
-TIA | 2 (1.0%) | |
-Valve thrombosis | 2 (1.0%) | |
Bleeding events, n (%) | 18 (9.0%) | 5.50 |
-Clinically significant | 9 (4.5%) | |
-Minor | 9 (4.5%) | |
Total events, n (%) | 31 (15.5%) | 4.38 |